<DOC>
	<DOCNO>NCT02218034</DOCNO>
	<brief_summary>This safety , tolerability pharmacokinetics study AGN-190168 subject acne vulgaris .</brief_summary>
	<brief_title>Safety , Tolerability Pharmacokinetics AGN-190168 Subjects With Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Tazarotene</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Diagnosis acne vulgaris face No tobacco use past 30 day , willing refrain nicotine use study Willing avoid excessive prolonged exposure treat skin ultraviolet light ( eg , sunlight , tan bed ) extremes weather , wind cold , throughout study If male , willing maintain routine shave regimen duration study avoid shave 12 hour prior specify visit Females childbearing potential must use reliable method contraception Use phototherapy device ( eg , ClearLight™ ) adhesive cleanse strip ( eg , Ponds® Biore® ) , well cosmetic procedure ( eg , facial , peel , comedone extraction ) area treat past 1 week Use topical antiinflammatory drug , salicylic acid ( eg , Clearasil® Clean &amp; Clear® ) , corticosteroid , antibiotic , antibacterial ( include benzoyl peroxidecontaining product [ eg , benzamycin ] ) , retinoids , topical acne treatment ( eg , photodynamic therapy , laser therapy , medicate soap ) area treat past 2 week Ability abstain caffeinecontaining product date instruct</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>